We are pleased to announce that the acquisition of Avid Bioservices by GHO Capital Partners and Ampersand Capital Partners has been completed. Read the Press Release
With services covering the development and manufacturing of both mammalian protein and viral vector-based therapies, we offer our clients full lifecycle capabilities, from concept to commercial supply.Â
Our experienced team offers end-to-end solutions, from early stage development to commercial scale production. With state-of-the-art facilities and expertise in bioprocess optimization, analytical testing, and regulatory compliance, we deliver high quality, reliable biologics.
We specialize in viral vector process development, optimization, and scalable production for gene therapy and vaccine applications. Our state-of-the-art facility, experienced team, and adherence to regulatory guidelines ensure safe and efficient manufacturing.
Our experts are fully committed to your success, advocating for you and helping to minimize risk.
© 2025 Avid Bioservices, Inc. All rights reserved.
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields